PTEN and non-small cell lung carcinoma: A representative NSCLC cell line of each group [“wild-type” (H460 cells), TKI-resistant (exon 19 and PTEN mutant, H1650 cells) and TKI-sensitive (exon 19 mutant, PC9 cells)] was selected for further study.